Back to top
more

Bellerophon Therapeutics (BLPH)

(Delayed Data from OTC)

$0.05 USD

0.05
4,754

0.00 (0.00%)

Updated Jul 15, 2024 09:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Company News for Feb 19, 2020

by Zacks Equity Research

Companies In The News Are:

Biotech Stock Roundup: INCY's Solid Q4 Results, EPZM & SGEN's Pipeline Updates

by Zacks Equity Research

It was a low-key week for the biotech sector with updates from just a few small biotech companies.

Moving Average Crossover Alert: Bellerophon Therapeutics (BLPH)

by Zacks Equity Research

Bellerophon Therapeutics, Inc. (BLPH) could be a stock to avoid from a technical perspective

    Indrajit Bandyopadhyay headshot

    5 Biotech Stocks Under $10 Worthy of Investors' Attention

    by Indrajit Bandyopadhyay

    Small biotech stocks are good bets with lower market cap as well as share price.

      The Zacks Analyst Blog Highlights: Comtech Telecommunications, Echo Global Logistics, Shoe Carnival, Bellerophon Therapeutics and OFG Bancorp

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Comtech Telecommunications, Echo Global Logistics, Shoe Carnival, Bellerophon Therapeutics and OFG Bancorp

        Swarup Gupta headshot

        Bet on 5 Top-Ranked Small Caps as Trade Tensions Escalate

        by Swarup Gupta

        With trade-related tensions refusing to die down, small-cap stocks are looking like an increasingly attractive proposition.

          Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher

          by Zacks Equity Research

          Exact Sciences Corporation (EXAS) was a big mover last session, as the company saw its shares rise nearly 12% on the day.

            Strength Seen in Alexion Pharmaceuticals (ALXN): Stock Soars 14.5%

            by Zacks Equity Research

            Alexion (ALXN) was a big mover last session, as the company saw its shares rise more than 14% on the day amid huge volumes.

              Debapriya Chakraborty headshot

              Pick 3 Biotech Money-Spinning Bets Amid Market Instability

              by Debapriya Chakraborty

              The drugs/biotech sector has been down since the past month, reeling under broader market pressures. Only a few good stocks however, remain out of this rut.

                Will Bellerophon Therapeutics (BLPH) Continue to Surge Higher?

                by Zacks Equity Research

                As of late, it has definitely been a great time to be an investor in Bellerophon Therapeutics, Inc. (BLPH).